These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10536125

  • 1. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG.
    N Engl J Med; 1999 Oct 28; 341(18):1336-43. PubMed ID: 10536125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ, Zanamivir Family Study Group.
    N Engl J Med; 2000 Nov 02; 343(18):1282-9. PubMed ID: 11058672
    [Abstract] [Full Text] [Related]

  • 5. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG, Jennings L, Robson R, Schiff G, Jackson H, Rana B, McClelland G, Ipe D, Roberts N, Ward P.
    Antivir Ther; 2000 Sep 02; 5(3):205-13. PubMed ID: 11075941
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.
    Clin Ther; 2007 Aug 02; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I.
    Kansenshogaku Zasshi; 2000 Dec 02; 74(12):1062-76. PubMed ID: 11193558
    [Abstract] [Full Text] [Related]

  • 8. Oseltamivir: a review of its use in influenza.
    McClellan K, Perry CM.
    Drugs; 2001 Dec 02; 61(2):263-83. PubMed ID: 11270942
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
    Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG.
    JAMA; 2000 Feb 23; 283(8):1016-24. PubMed ID: 10697061
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A.
    J Infect; 2000 Jan 23; 40(1):42-8. PubMed ID: 10762110
    [Abstract] [Full Text] [Related]

  • 11. Neuraminidase inhibitors: zanamivir and oseltamivir.
    McNicholl IR, McNicholl JJ.
    Ann Pharmacother; 2001 Jan 23; 35(1):57-70. PubMed ID: 11197587
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.
    N Engl J Med; 1998 May 14; 338(20):1405-12. PubMed ID: 9580647
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F.
    Arch Intern Med; 2003 Jul 28; 163(14):1667-72. PubMed ID: 12885681
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb 28; 15(81):21-30. PubMed ID: 16548114
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG, Szakaly P, Shapira MY, Kriván G, Nist A, Dutkowski R.
    Antivir Ther; 2012 Feb 28; 17(6):955-64. PubMed ID: 22728756
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K, Ogawa N, Nerome K, Numazaki Y, Kawakami Y, Shirato K, Arakawa M, Kudoh S, Shimokata K, Nakajima S, Yamakido M, Kashiwagi S, Nagatake T.
    Antivir Ther; 1999 Feb 28; 4(2):61-8. PubMed ID: 10682150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.